This is a regulatory disclosure submitted to the National Stock Exchange of India Limited and BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 issued on July 11, 2023, and last updated on January 30, 2026.
The disclosure intimates the resignation of Dr. Manish Mattoo from the office of Interim Chief Financial Officer of HealthCare Global Enterprises Limited. The resignation is effective from May 25, 2026.
The cessation is a direct consequence of the appointment of Mr. Sanjeev Kumar as the new Chief Financial Officer and Key Managerial Personnel of the Company. Mr. Kumar's appointment was approved by the Board of Directors at its meeting held on May 19, 2026, and he assumed office effective May 25, 2026.
Dr. Manish Mattoo, who is the Executive Director and Chief Executive Officer of the Company, was holding the additional charge of Interim CFO. His interim appointment was originally approved by the Board of Directors at its meeting held on December 01, 2025, based on the recommendations of the Audit Committee and the Nomination and Remuneration Committee. The tenure was intended to last until a new CFO was appointed and assumed charge.
The Company has placed on record its deep appreciation for the leadership, commitment, and valuable contributions rendered by Dr. Manish Mattoo during his tenure as the Interim Chief Financial Officer.
The submission includes two annexures:
- Annexure-A: A formatted disclosure table as required by the SEBI Listing Regulations and Master Circular.
- Annexure-B: The resignation letter received from Dr. Manish Mattoo.
The letter is signed by Sunu Manuel, Company Secretary and Compliance Officer, for HealthCare Global Enterprises Limited.